A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy - Summary - MDSpire
Advertisement
A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy
To evaluate the effectiveness of a comprehensive dental intervention for the assessment and management of oral health in patients with solid tumors during cancer therapy using e-health applications, with a specific focus on comparing outcomes to standard oncology-based oral care.
Key Findings:
Telemedicine significantly improved oral-health outcomes and oral-care behaviors compared to controls, with p-values indicating statistical significance.
At mid-treatment and treatment completion, the intervention group showed lower rates of mucosal lesions, gingival bleeding, gingivitis, and dental caries.
Higher tooth-brushing frequency was observed in the intervention group.
Interpretation:
Telemedicine and e-health tools enable effective monitoring, early-stage detection, and oral self-care guidance, leading to improved oral health and well-being during and after cancer treatment, suggesting a need for broader implementation in oncology care.
Limitations:
The study was limited to a specific patient population (breast, lung, or colon cancer), which may not represent all cancer types.
Results may not be generalizable to all cancer types or treatment regimens, and potential biases or confounding factors were not fully addressed.
Conclusion:
Integration of structured teledentistry monitoring into oncology care was associated with improved oral health outcomes in patients undergoing antineoplastic therapy, compared to usual practice.